-
Mashup Score: 2Long-term air pollution exposure and the risk of primary graft dysfunction after lung transplantation - 11 hour(s) ago
Primary graft dysfunction (PGD) contributes substantially to both short- and long-term mortality after lung transplantation, but the mechanisms that lead to PGD are not well understood. Exposure to ambient air pollutants is associated with adverse events during waitlisting for lung transplantation and chronic lung allograft dysfunction, but its association with PGD has not been studied. We hypothesized that long-term exposure of the lung donor and recipient to high levels of ambient air pollutants would increase the risk of PGD in lung transplant recipients.
Source: www.jhltonline.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 6An integrated sampling strategy for therapeutic mycophenolic acid monitoring in lung transplant recipients - 5 day(s) ago
Mycophenolic Acid (MPA) is the most used anti-proliferative in lung transplantation, but its pharmacokinetic (PK) variability has precluded therapeutic drug monitoring. Both genetic and clinical factors have been implicated in MPA variability. This study aimed to integrate genetic and clinical factors with PK measurements to quantify MPA exposure.
Source: www.jhltonline.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 12Hospital volume does not mitigate the impact of area socioeconomic deprivation on heart transplantation outcomes - 10 day(s) ago
While structural socioeconomic inequity has been linked with inferior health outcomes, some have postulated reduced access to high-quality care to be the mediator. We assessed whether treatment at high-volume centers (HVC) would mitigate the adverse impact of area deprivation on heart transplantation (HT) outcomes.
Source: www.jhltonline.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3
Previous studies have demonstrated the safety of pulmonary endarterectomy (PEA) across body mass index (BMI) strata. However, long-term survival and patient-reported outcome measures by BMI strata remain unknown. We examined the impact of preoperative BMI on long-term survival, QOL, and functional outcomes for patients undergoing PEA for chronic thromboembolic pulmonary hypertension (CTEPH).
Source: www.jhltonline.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 24A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension - 18 day(s) ago
Despite increasing therapeutic options and evolving treatment strategies, including targeting 3 therapeutic pathways, in the management of pulmonary arterial hypertension (PAH), morbidity and mortality have remained unacceptably high. Sotatercept is a first-in-class, novel activin signaling inhibitor approved for treating PAH based on evolving efficacy and safety evidence. This state-of-the-art review summarizes the current understanding of the mechanism of action, the impact on outcomes that improve how patients feel, function, and survive, and the safety and adverse event profile to inform readers of this breakthrough novel therapy.
Source: www.jhltonline.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 4Detailed cellular and spatial characterization of chronic lung allograft dysfunction using imaging mass cytometry - 18 day(s) ago
Long-term survival after lung transplantation remains limited by chronic lung allograft dysfunction (CLAD), with 2 main phenotypes: bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS). We aimed to assess CLAD lung allografts using imaging mass cytometry (IMC), a high dimensional tissue imaging system allowing a multiparametric in situ exploration at a single cell level. Four BOS, 4 RAS, and 4 control lung samples were stained with 35 heavy metal-tagged antibodies selected to assess structural and immune proteins of interest.
Source: www.jhltonline.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 12
Real-time lung weight (LW) measurement is a simple and noninvasive technique for detecting extravascular lung water during ex vivo lung perfusion (EVLP). We investigated the feasibility of real-time LW measurement in clinical EVLP as a predictor of transplant suitability and post-transplant outcomes.
Source: www.jhltonline.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 9
Mortality risk assessment informs clinical management of pulmonary arterial hypertension (PAH). The Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) Lite 2 is a simplified risk calculator discriminating 1-year mortality risk.
Source: www.jhltonline.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 8Immunomodulatory soluble HLA-G and HLA-E are associated with rapidly deteriorating CLAD and HCMV viremia after lung transplantation - 24 day(s) ago
Plasma-soluble (s)HLA-G and sHLA-E are immunoregulatory proteins that balance the activation of NKG2A+ immune cells. In lung-transplant recipients (LTRs), dysregulated NKG2A+ natural killer cell responses may result in high-level human cytomegalovirus (HCMV) replication as well as chronic lung allograft dysfunction (CLAD), and especially the development of rapidly deteriorating CLAD is associated with high mortality. We thus analyzed the kinetics and function of sHLA-G and sHLA-E in follow-up samples of N = 76 LTRs to evaluate whether these immunoregulatory proteins are associated with the risk for CLAD and high-level HCMV replication.
Source: www.jhltonline.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 8Amniotic fluid-derived mesenchymal stem cells reduce inflammation and improve lung function following transplantation in a porcine model - 25 day(s) ago
Lung transplantation is hindered by low donor lung utilization rates. Infectious complications are reasons to decline donor grafts due to fear of post-transplant primary graft dysfunction. Mesenchymal stem cells are a promising therapy currently investigated in treating lung injury. Full-term amniotic fluid-derived lung-specific mesenchymal stem cell treatment may regenerate damaged lungs. These cells have previously demonstrated inflammatory mediation in other respiratory diseases, and we hypothesized that treatment would improve donor lung quality and postoperative outcomes.
Source: www.jhltonline.orgCategories: General Medicine News, CardiologistsTweet
Does long-term air pollution exposure impact the lung allograft? 🫁 A recent study shows no strong associations between air pollutant exposures in either the donor or the recipient and PGD. 🔗: https://t.co/G2hjOiuFlI